Oncostatin M (OSM) is a member of the IL-6 cytokine family with gp130 as a common receptor subunit [10]; OSM gene expression in intestinal mucosal tissues has been reported to be a predictor of the efficacy of anti-TNF-α antibody preparations in patients with IBD [11]. The gene discussed is OSM; the disease is inflammatory bowel disease.